Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.0750
+0.0050 (7.14%)
Mar 28, 2025, 11:02 AM EST
Britannia Life Sciences Revenue
Britannia Life Sciences had revenue of 1.74M CAD in the quarter ending December 31, 2024, a decrease of -4.02%. This brings the company's revenue in the last twelve months to 7.19M, down -3.93% year-over-year. In the fiscal year ending March 31, 2024, Britannia Life Sciences had annual revenue of 7.57M with 18.20% growth.
Revenue (ttm)
7.19M
Revenue Growth
-3.93%
P/S Ratio
1.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 7.57M | 1.17M | 18.20% |
| Mar 31, 2023 | 6.40M | -896.10K | -12.28% |
| Mar 31, 2022 | 7.30M | 5.88M | 412.42% |
| Mar 31, 2021 | 1.42M | - | - |
| Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| WELL Health Technologies | 957.69M |
| Extendicare | 1.47B |
| Curaleaf Holdings | 1.93B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 169.23M |